Clinical efficacy of probiotic Bifidobacterium longum for the treatment of symptoms of Japanese cedar pollen allergy in subjects evaluated in an environmental exposure unit

Allergology International

Volumn 56, Issue 1, 2007, Pages 67-75

  Xiao, Jin Zhong ^a   Kondo, Shizuki ^a   Yanagisawa, Naotake ^a   Miyaji, Kazuhiro ^a   Enomoto, Keisuke ^b   Sakoda, Takema ^c   Iwatsuki, Keiji ^a   Enomoto, Tadao ^c  

^a MORINAGA MILK INDUSTRY CO LTD   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c JAPANESE RED CROSS WAKAYAMA MEDICAL CENTER   (Japan)

Author keywords

Allergy; Bifidobacterium; Environmental exposure unit (EEU); Japanese cedar pollinosis; Probiotic

Indexed keywords

PLACEBO; PROBIOTIC AGENT;

AREA UNDER THE CURVE; ARTICLE; BIFIDOBACTERIUM LONGUM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; JAPANESE; MALE; POLLEN ALLERGY; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 33947430121     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.O-06-455     Document Type: Article

References (25)

1. Settipane RA Demographics and epidemiology of allergic and nonallergic rhinitis. Allergy Asthma Proc. 2001;22:185-189.
2. Heinrich J, Richter K, Frye C et al. European Community Respiratory Health Survey in Adults (ECRHS). Pneumologie 2002;56:297-303.
3. Enomoto T. Reevaluation of hygiene theory. Arerugi 2004;53:465-468.
4. Akdis CA, Blaser K, Akdis M. Mechanisms of allergen-specific immunotherapy. Chem. Immunol. Allergy 2006;91:195-203.
5. Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J. Allergy Clin. Immunol. 1997;99:179-185.
6. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001;357:1076-1079.
7. Wang MF, Lin HC, Wang YY, Hsu CH. Treatment of perennial allergic rhinitis with lactic acid bacteria. Pediatr. Allergy Immunol. 2004;5:152-158.
8. Ishida Y, Nakamura F, Kanzato H et al. Clinical effects of Lactobacillus acidophilus strain L-92 on perennial allergic rhinitis: a double-blind, placebo-controlled study. J. Dairy Sci. 2005;88:527-533.
9. Peng GC, Hsu CH. The efficacy and safety of heat-killed Lactobacillus paracasei for treatment of perennial allergic rhinitis induced by house-dust mite. Pediatr. Allergy Immunol. 2005;16:433-438.
10. Viljanen M, Savilahti E, Haahtela T et al. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy 2005;60:494-500.
11. Helin T, Haahtela S, Haahtela T. No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: a placebo-controlled double-blind study. Allergy 2002;57:243-246.
12. Xiao JZ, Kondo S, Yanagisawa N et al. Effect of Probiotic Bifidobacterium longum BB536 in relieving clinical symptoms and modulating plasma cytokine levels of Japanese cedar pollinosis during the pollen season, a randomized, double-blind, placebo-controlled trial. J. Invest. Allergol. Clin. Immunol. 2006;16:86-93.
13. Xiao JZ, Kondo S, Yanagisawa N et al. Probiotics in the treatment of Japanese cedar pollinosis: a double-blind placebo-controlled trial. Clin. Exp. Allergy. In press 2006.
14. Enomoto T, Ide T, Ogino S. Development of an environmental exposure unit and effects of Cetirizine Hydrocholorine on relieving the symptom of cedar pollinosis. Progress in Medicine 2005;25:3141-3149.
15. Enomoto T, Sakoda T, Yoda S, Dake Y, Ide T. Clinical efficacy of olobatadine hydrochloride (Allelock®) and fexofenadine hydrochloride (Allegra®) on Japanese cedar pollinosis: study in an environmental exposure unit. Allergology & Immunology 2006;15:1268-1276.
16. Day JH, Briscoe MP. Environmental exposure unit: a system to test anti-allergic treatment. Ann. Allergy Asthma Immunol. 1999;83:83-89.
17. Day JH, Briscoe MP, Rafeiro E, Ratz JD. Comparative clinical efficacy, onset and duration of action of levocetirizine and desloratadine for symptoms of seasonal allergic rhinitis in subjects evaluated in the Environmental Exposure Unit (EEU). Int. J. Clin. Pract. 2004;58:109-118.
18. Stubner P, Zieglmayer R, Horak F. A direct comparison of the efficacy of antihistamines in SAR and PAR randomised, placebo-controlled studies with levocetirizine and loratadine using an environmental exposure unit - the Vienna Challenge Chamber (VCC). Curr. Med. Res. Opin. 2004;20:891-902.
19. Wilken JA, Kane RL, Ellis AK et al. A comparison of the effect of diphenhydramine and desloratadine on vigilance and cognitive function during treatment of ragweed-induced allergic rhinitis. Ann. Allergy Asthma Immunol. 2003;91:375-385.
20. Krug N, Hohlfeld JM, Geldmacher H et al. Effect of loteprednol etabonate nasal spray suspension on seasonal allergic rhinitis assessed by allergen challenge in an environmental exposure unit. Allergy 2005;60:354-359.
21. Lukacs NW. Role of chemokines in the pathogenesis of asthma. Nat. Rev. Immunol. 2001;1:108-116.
22. Miescher SM, Vogel M. Molecular aspects of allergy. Mol. Aspects Med. 2002;23:413-462.
23. Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern. Med. Rev. 2003;8:223-246.
24. Matricardi PM, Bjorksten B, Bonini S et al. EAACI Task Force 7. Microbial products in allergy prevention and therapy. Allergy 2003;58:461-471.
25. Kalliomaki MA, Isolauri E. Probiotics and down-regulation of the allergic response. Immunol. Allergy Clin. North Am. 2004;24:739-752.